Editorial: Screening for BK virus in pediatric renal transplant recipients

Pediatric Transplantation

Volumn 14, Issue 5, 2010, Pages 559-560

  Smith, Jodi M ^a   Davis, Connie L ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; IMMUNOGLOBULIN; LEFLUNOMIDE; QUINOLONE DERIVATIVE;

BK VIRUS; CYTOMEGALOVIRUS; EDITORIAL; EPSTEIN BARR VIRUS; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY GRAFT; PEDIATRIC SURGERY; RENAL GRAFT DYSFUNCTION; KIDNEY TRANSPLANTATION; MASS SCREENING; POLYOMAVIRUS INFECTION; VIRUS INFECTION;

BK VIRUS; HUMANS; KIDNEY TRANSPLANTATION; MASS SCREENING; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

EID: 77954477528     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2010.01346.x     Document Type: Editorial

References (15)

1. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005 : 79 : 1277 1286.
2. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 : 347 : 488 496.
3. Buehrig CK, Lager DJ, Stegall MD, et al. Influence of surveillance renal allograft biopsy on diagnosis and prognosis of polyomavirus-associated nephropathy. Kidney Int 2003 : 64 : 665 673.
4. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant. Am J Transplant 2009 : 9 (Suppl 3 S1 S155.
5. Smith JM, Dharnidharka V, Talley L, Mcdonald RA. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the NAPRTCS registry. Clin J Am Soc Nephrol 2007 : 2 : 1037 1042.
6. Laskin B, Goebel J. Cost efficient screening for BK Virus in pediatric kidney transplantation: A single center experience and review of the literature. Pediatr Transplant 2010 : 14 : 589 595.
7. Smith F, Panek R, Kiberd BA. Screening to prevent polyoma virus nephropathy in kidney transplantation: A cost analysis. Am J Transplant 2009 : 9 : 2177 2179.
8. Knowles WA, Pillay D, Johnson MA, et al. Prevalence of long-term BK and JC excretion in HIV-infected adults and lack of correlation with serological markers. J Med Virol 1999 : 59 : 474.
9. Shah KV, Daniel RW, Warszawski RM. High prevalence of antibodies to BK virus, an SV40-related papovavirus, in residents of Maryland. J Infect Dis 1973 : 128 : 784.
10. Stolt A, Sasnauskas K, Koskela P, et al. Seroepidemiology of the human polyomaviruses. J Gen Virol 2003 : 84 : 1499.
11. Randhawa PS, Gupta G, Vats A, et al. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 2006 : 13 : 1057.
12. Ginevri F, De Santis R, Comoli P, et al. Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches. Transplantation 2003 : 8 : 1266 1270.
13. Smith JM, Mcdonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyoma virus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004 : 4 : 2109 2117.
14. Womer KL, Huang Y, Herren H, et al. Dendritic cell deficiency associated with development of BK viremia and nephropathy in renal transplant recipients. Transplantation 2010 : 1 : 115 123.
15. Egli A, Köhli S, Dickenmann M, Hirsch HH. Inhibition of polyomavirus BK-specific T-cell responses by immunosuppressive drugs. Transplantation 2009 : 10 : 1161 1168.